While the Democratic-run House is expected this week to pass a bill that would decriminalize marijuana at the federal level, some analysts say that for the next Congress the odds of cannabis legislation becoming law stand at less than 25%.
Gold futures aim to add to gains on Wednesday after a sharp rally in the session prior, with bullion buoyed by seasonal buying trends that have momentarily overshadowed a perkier dollar and lofty government bond yields.
Companies more tolerant of differences in sexuality and gender identity have seen a stock-price boost as well, according to an analysis from Credit Suisse.
Carlo La Vecchia, from the University of Milan, explains what’s behind the second COVID-19 wave, why Germany has fared better than most other countries, and how to safely enjoy Christmas.
Deadlines have come and gone in the last 10 months, but the legal calendar now only leaves a few days for both sides to strike a deal in time for its ratification by parliaments.
Oil futures settle lower on Monday, under pressure as the Organization of the Petroleum Exporting Countries and its allies continue to debate whether to delay an easing of output curbs due to take place in January.
The stock market is wrapping up a historic November rally, but if history is a guide, the largest monthly gain on record for the small-cap Russell 2000 and big advances by other major indexes point to a potentially choppy period ahead, Wall Street pros warn.
Arizona certified President-elect Joe Biden as the winner of the state’s 11 electoral votes Monday afternoon, while the Wisconsin Elections Commission made official a pair of county recounts that increased Biden’s lead in the state by 87 votes to 20,695.
Tesla shares are up almost 600% this year, surpassing Warren Buffett’s Berkshire Hathaway with an eye-popping $555 billion valuation that dwarfs all car-making rivals. But will it last?
Stocks end lower Monday in the last trading session of November, but equities still manage to log a monthly return for equity-market annals as progress toward COVID-19 vaccines helps investors look past a scary resurgence of the disease derived from the novel strain of coronavirus.
“We believe that eliminating the decades-old revolving door between Silicon Valley and your administration will only help your cause,” according to the letter, signed by consumer rights, antitrust reform, and labor and progressive organizations that include Public Citizen, American Economic Liberties Project, and Open Markets Institute.